Tag: TSX:CSCI

COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update

COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq, while retaining the Company’s listing on the TSX

COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders

TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today announced the voting results on the items of business considered at the virtual annual general and special meeting of shareholders of the Company (the “AGSM”) held today.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsTSX:CSCI

APsystems Unveils New Hybrid & Off-Grid Energy Storage Solutions at SNEC 2026

In HelloNation, Insurance Expert Craig Willoughby of Buffalo, NY, Discusses What’s Included in Homeowners Insurance Policies

Stop duct-taping human email into machine workflows: Meet Hostinger Agentic Mail

Tag: TSX:CSCI

COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update

COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us